Author Question: The nurse knows that when combined continuous estrogen-progesterone therapy (CCEPT) is prescribed, ... (Read 56 times)

Arii_bell · **on:** Jun 25, 2018

The nurse knows that when combined continuous estrogen-progesterone therapy (CCEPT) is prescribed, the drug is considered effective if which of the following occurs?

A)
More regular periods for women with irregular menses
B)
Inhibited endometrial development resulting in no menses
C)
Relaxation of the myometrium, thereby limited painful cramps
D)
Shedding of the endometrial build-up on a more regular basis

Question 2

A 31-year-old male has been referred to a fertility clinic following a count of 2 million sperm/mL on seminal fluid analysis.

Which of the following hormone levels would a clinician want to examine in an effort to ascertain the cause of the client's low sperm count? Select all that apply.
A)
Luteinizing hormone (LH)
B)
Adrenocorticotropic hormone (ACTH)
C)
Follicle-stimulating hormone (FSH)
D)
Cortisol
E)
Somatostatin
F)
Gonadotropin-releasing hormone (GnRH)

hramirez205 · **Reply #1 on:** Jun 25, 2018

Answer to Question 1

Ans:
B

Feedback:

Thus, continuous exposure to progesterone inhibits endometrial development. Eventually, the combined continuous estrogen-progesterone therapy (CCEPT) results in no bleeding. It can be associated with irregular bleeding and spotting until the lining becomes atrophic. It relieves cramps rather than generating them.

Answer to Question 2

Ans:
A, C, F

Feedback:

LH, FSH, and GnRH are all components of the hypothalamic-pituitary control of spermatogenesis. ACTH, cortisol, and somatostatin are not directly involved in the process.